New hope for stubborn heartburn? experimental pill enters testing
NCT ID NCT06704100
Summary
This study is testing whether a new oral medication called FOS-SA can reduce symptoms in people with persistent acid reflux disease (GERD) that doesn't get better with standard heartburn pills. About 60 participants will take either the study drug or a placebo twice daily for 8 weeks while tracking their symptoms. Researchers will compare the two groups to see if FOS-SA is better at easing heartburn severity and regurgitation frequency.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.